umbilical cord blood plasma
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2018 (NCT03229785)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- PlasmaSupplementation
Plasma supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04566757 | Phase 1 | Dec 1, 2020 | American Academy of Regenerative Medicine |
| NCT03229785 | Phase 1 | Apr 1, 2018 | Hexagon Therapies, LLC |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| American Academy of Regenerative Medicine | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Hexagon Therapies, LLC | For profit | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1